These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
48. [Idiopathic retroperitoneal fibrosis: a case report without increased levels of acute-phase reactants. Noninvasive diagnosis and treatment]. Artom A; Gandolfo N Ann Ital Med Int; 2004; 19(1):50-3. PubMed ID: 15176708 [TBL] [Abstract][Full Text] [Related]
50. [Clinical features and prognostic analysis of retroperitoneal fibrosis in 32 patients]. An LM; Xu YF; Zhang ZL Beijing Da Xue Xue Bao Yi Xue Ban; 2012 Apr; 44(2):265-9. PubMed ID: 22517001 [TBL] [Abstract][Full Text] [Related]
52. Retroperitoneal fibrosis: a retrospective clinical data analysis of 30 patients in a 10-year period. Zhou HJ; Yan Y; Zhou B; Lan TF; Wang XY; Li CS Chin Med J (Engl); 2015 Mar; 128(6):804-10. PubMed ID: 25758277 [TBL] [Abstract][Full Text] [Related]
53. Treatment of retroperitoneal fibrosis with tamoxifen. Spillane RM; Whitman GJ AJR Am J Roentgenol; 1995 Feb; 164(2):515-6. PubMed ID: 7840016 [No Abstract] [Full Text] [Related]
54. IgG4-related retroperitoneal fibrosis: a newly characterized disease. Lian L; Wang C; Tian JL Int J Rheum Dis; 2016 Nov; 19(11):1049-1055. PubMed ID: 27125330 [TBL] [Abstract][Full Text] [Related]
55. Value of acute-phase reactants in monitoring disease activity and treatment response in idiopathic retroperitoneal fibrosis. Pelkmans LG; Aarnoudse AJ; Hendriksz TR; van Bommel EF Nephrol Dial Transplant; 2012 Jul; 27(7):2819-25. PubMed ID: 22273666 [TBL] [Abstract][Full Text] [Related]